Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

All GLG News Analyses Filed Under: Ophthalmology

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Andrew Dahl, MDPresident Ophthalmology Consultants What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Lumigan X EU Committee Recomendation

October 27, 2009

 EU committee backs marketing approval of Lumigan | www.pharmabiz.com

The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan anew...

NO BRAINER: Genentech Prefers to Promote Lucentis over Avastin for Wet ARMD

October 7, 2009

GLG Expert Contributor

 Genentech revisits plan for Avastin | www.sfgate.com

It does not require a lot of ophthalmic and business savy to understand why a company rather promote a drug that costs more than 20 times more to treat the same medical condition.

Steve Rubinstein, OD, Optometrist

Steve Rubinstein, ODOptometristSound Shore Vision Care What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Contact Lens Nirvana: Hyperpermeable One Day

October 2, 2009

 Hobby assists Irish strategy | www.opticianonline.net

 This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.

Mark Packer, MD, Clinical Associate Professor of Ophthalmology

Mark Packer, MDClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Tecnis Multifocal Outperforms Competitors

September 20, 2009

 Summary of Safety and Effectiveness Data (FDA) | www.fda.gov

The US Clinical Investigation of the Tecnis Multifocal demonstrated 88% complete freedom from glasses at 6 months, and 95% satisfaction at one year.  A comparable study of the ReStor lenses, with both 3 and 4 diopter adds, demonstrated 76% freedom from glasses at 4 - 6 months.  Despite a one line lower...

Mark Packer, MD, Clinical Associate Professor of Ophthalmology

Mark Packer, MDClinical Associate Professor of OphthalmologyOREGON HEALTH & SCIENCE UNIVERSITY - CC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

AMO Grows Portfolio, Potential with Acquisition of Accommodating Lens Implant

September 3, 2009

 Abbott to Acquire Visiogen, Expanding Vision Care Portfolio | www.abbott.com

 It was announced today that Abbot Labs intends to acquire Visiogen (Santa Ana, CA) for $400 million in cash.  Earlier this year Abbott acquired Advanced Medical Optics, manufacturer of the Tecnis Multifocal IOL and the VISX excimer laser.  Visiogen's accommodating IOL, called Synchrony, is designed...

Steve Rubinstein, OD, Optometrist

Steve Rubinstein, ODOptometristSound Shore Vision Care What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?

July 23, 2009

 Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com

This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca  to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.

Catract Surgery and Premium IOLs

July 19, 2009

GLG Expert Contributor

 FDA Approves Alcon's AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens - New Lens Corrects For Cataracts With Presbyopia | www.medicalnewstoday.com

The Alcon ReStor+3 allows an extended range of unaided vision post cataract or clear lens removal. The ReStor+3 model allows a comfortable intermediate reading and distance vision without spectacle correction. . The production ofpremium IOLs promises to increase significantly to the benefit of Alcon,...

Gary Barker, Partner/Owner

Gary BarkerPartner/OwnerEYE ASSOCIATES OF WINTER PARK What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Welcome addition to our armament, but overuse potential?

July 14, 2009

 Bausch and Lomb (BOL) Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') | www.lifescience-online.com

Potential for overuse and more drug-resistant bacteria

Alcon ReStor +3 offers excellent near, intermediate, and distance vision

July 14, 2009

GLG Expert Contributor

 FDA Approves Alcon's AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens - New Lens Corrects For Cataracts With Presbyopia | www.medicalnewstoday.com

good range of vision; less glare than the competition, great visual results after cataract surgery

Vincent de Luise, MD, Assistant Clinical Professor of Ophthalmology

Vincent de Luise, MDAssistant Clinical Professor of Ophthalmology YALE UNIVERSITY What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Technical analysis of multifocal lens implants (IOLs) and astigmatism lens implants (Toric IOLs)

July 14, 2009

 FDA Approves Alcon's AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens - New Lens Corrects For Cataracts With Presbyopia | www.medicalnewstoday.com

 There is a sea-change in cataract/lens implant (IOL) surgery.  More than ever before, patients with cataracts want to able to see well without the need for glasses or contact lenses. Standard IOLs give very good vision, but many patients have pre-existing astigmatism and need...

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 302

Request a News Analysis

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Leading institutions connect with members of the Healthcare councils through GLG

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
7 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

Most Popular Healthcare News